Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy

Journal of Hepatology

Volumn 57, Issue 6, 2012, Pages 1251-1257

  Toyoda, Hidenori ^a   Kumada, Takashi ^a   Tada, Toshifumi ^a   Niinomi, Takuro ^a   Ito, Takanori ^a   Kaneoka, Yuji ^a   Maeda, Atsuyuki ^a  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Curative hepatectomy; Hepatocellular carcinoma; Recurrence; Survival; Tumor markers

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; LENS CULINARIS AGGLUTININ REACTIVE ALPHA FETOPROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POST TREATMENT SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR GROWTH;

AGED; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLANT LECTINS; PROGNOSIS; PROTEIN PRECURSORS; PROTHROMBIN; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84869229207     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.07.018     Document Type: Article

References (26)

1. D. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2002 74 108
2. A.S. Befeler, and A.M. DiBisceglie Hepatocellular carcinoma: diagnosis and treatment Gastroenterology 122 2002 1609 1619
3. T. Umemura, and K. Kiyosawa Epidemiology of hepatocellular carcinoma in Japan Hepatol Res 37 2007 S95 100
4. H. Tsukuma, T. Hiyama, S. Tanaka, M. Nakao, T. Yabuuchi, and T. Kitamura Risk factors for hepatocellular carcinoma among patients with chronic liver disease N Engl J Med 328 1993 1797 1801
5. K. Taketa, C. Sekiya, N. Namiki, K. Akamatsu, Y. Ohta, and Y. Endo Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions Gastroenterology 99 1990 508 518
6. H.A. Liebman, B.C. Furie, M.J. Tong, R.A. Blanchard, K.J. Lo, and S.D. Lee Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma N Engl J Med 310 1984 1427 1431
7. S. Fujiyama, M. Tanaka, S. Maeda, H. Ashihara, R. Hirata, and K. Tomita Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma Oncology 62 2002 S57 63
8. H. Toyoda, T. Kumada, S. Kiriyama, Y. Sone, M. Tanikawa, and Y. Hisanaga Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma Clin Gastroenterol Hepatol 4 2006 111 117
9. S.H. Kang, D.Y. Kim, S.M. Jeon, S.H. Ahn, J.Y. Park, and S.U. Kim Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels Eur J Gastroenterol Hepatol 24 2012 849 856
10. N. Kokudo, and M. Makuuchi Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: J-HCC guidelines J Gastroenterol 44 2009 S119 121
11. R. Ramerz AFP (alpha-fetoprotein) L. Thomas, Clinical and Laboratory Diagnosis English ed. 1998 TH-Books Verlagsgesellschaft mbH Frankfurt/Main 941 945
12. M. Furukawa, T. Nakanishi, H. Okuda, S. Ishida, and H. Obata Changes of plasma des-Υ-carboxy prothrombin levels in patients with hepatocellular carcinoma in response to vitamin K Cancer 69 1992 31 38
13. C. Kagebayashi, I. Yamaguchi, A. Akinaga, H. Kitano, K. Yokoyama, and M. Satomura Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis Anal Biochem 388 2009 306 311
14. H. Oka, A. Tamori, T. Kuroki, K. Kobayashi, and S. Yamamoto Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma Hepatology 19 1994 61 66
15. M. Koda, Y. Murawaki, A. Mitsuda, K. Ohyama, Y. Horie, and T. Suou Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma Cancer 88 2000 529 537
16. H. Toyoda, T. Kumada, T. Tada, Y. Kaneoka, A. Maeda, and F. Kanke Clinical utility of high sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/ml Cancer Sci 102 2011 1025 1031
17. H. Okuda, T. Nakanishi, K. Takatsu, A. Saito, N. Hayashi, and K. Takasaki Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathological features of solitary hepatocellular carcinoma Cancer 88 2000 544 549
18. E.L. Kaplan, and P. Meier Non parametric estimation for incomplete observation J Am Stat Assoc 53 1958 457 481
19. R. Petro, and M.C. Pike Conservation of the approximation (0-E2)/E in the log rank test for survival data on tumor incidence data Biometrics 29 1973 579 584
20. D. Cox Regression models and life tables J R Stat Soc 34 1972 187 220
21. R.N.H. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
22. S. Kiriyama, K. Uchiyama, M. Ueno, S. Ozawa, S. Hayami, and M. Tani Triple positive tumor markers for hepatocellular carcinoma are useful predictor of a poor survival Ann Surg 254 2011 984 991
23. Y. Aoyagi, O. Isokawa, T. Suda, M. Watanabe, Y. Suzuki, and H. Asakura The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma Cancer 83 1998 2076 2082
24. Y. Koike, Y. Shiratori, S. Sato, S. Obi, T. Teratani, and M. Imamura Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients Cancer 91 2001 561 569
25. H. Toyoda, T. Kumada, Y. Kaneoka, and A. Maeda Amino acid substitutions in the hepatitis C virus core region are associated with postoperative recurrence and survival of patients with HCV genotype 1b-associated hepatocellular carcinoma Ann Surg 254 2011 326 332
26. T. Kumada, S. Nakano, I. Takeda, K. Sugiyama, T. Osada, and S. Kiriyama Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma Hepatology 25 1997 87 92